ArticleJournal of nanobiotechnology2025

RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease.

Zhaochen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.